NDC Compounded Drug 63037-101-05 Fentanyl Citrate
Injection Intravenous
Compounded Drug Product Information
NDC Crossover Products Matching Fentanyl Citrate
NDC crossover of Fentanyl Citrate In 0.9% Sodium Chloride with NDC 63037-101 a human compounded drug with other similar products matching the same substance name (Fentanyl Citrate) and the same administration route (intravenous) or dosage form (injection).
NDC | Proprietary Name | Non-Proprietary Name | Package Desc | Dosage Form | Route Name | Company Name |
---|---|---|---|---|---|---|
51754-9150-1 | Fentanyl Citrate | Fentanyl Citrate Injection 2500 Mcg/50 Ml | 50 mL in 1 VIAL, GLASS | Injection | Intravenous | Exela Pharma Sciences, Llc. |
51754-9160-1 | Fentanyl Citrate | Fentanyl Citrate Injection 5000 Mcg/100 Ml | 100 mL in 1 VIAL, GLASS | Injection | Intravenous | Exela Pharma Sciences, Llc. |
60652-6030-1 | Fentanyl Citrate Drip | Fentanyl Citrate Drip | 50 mL in 1 BAG | Injection | Intravenous | Ssm Hlth St Clare Hosp-fnton |
60652-6030-1 | Fentanyl Citrate Drip | Fentanyl Citrate Drip | 50 mL in 1 BAG | Injection | Intravenous | Ssm Hlth St Clare Hosp-fnton |
60652-6030-1 | Fentanyl Citrate Drip | Fentanyl Citrate Drip | 50 mL in 1 BAG | Injection | Intravenous | Ssm Health Care St. Louis D/b/a Ssm Health St. Clare-fenton |
60652-6030-1 | Fentanyl Citrate Drip | Fentanyl Citrate Drip | 50 mL in 1 BAG | Injection | Intravenous | Ssm Hlth St Clare Hosp-fnton |
60652-9010-1 | Fentanyl Citrate | Fentanyl Citrate | 1 mL in 1 VIAL, GLASS | Injection | Intravenous | Ssm Hlth St Clare Hosp-fnton |
63037-100-05 | Fentanyl Citrate In 0.9 % Sodium Chloride | Fentanyl Citrate In 0.9% Sodium Chloride Injection | 100 mL in 1 BAG | Injection | Intravenous | Hikma Injectables Usa Inc. |
63037-100-05 | Fentanyl Citrate In 0.9 % Sodium Chloride | Fentanyl Citrate In 0.9% Sodium Chloride Injection | 100 mL in 1 BAG | Injection | Intravenous | Hikma Injectables Usa Inc. |
63037-100-05 | Fentanyl Citrate In 0.9 % Sodium Chloride | Fentanyl Citrate In 0.9% Sodium Chloride Injection | 100 mL in 1 BAG | Injection | Intravenous | Hikma Injectables Usa Inc. |
63037-100-05 | Fentanyl Citrate In 0.9 % Sodium Chloride | Fentanyl Citrate In 0.9% Sodium Chloride Injection | 100 mL in 1 BAG | Injection | Intravenous | Hikma Injectables Usa Inc. |
63037-190-25 | Fentanyl Citrate | Fentanyl Citrate | 2 mL in 1 SYRINGE, PLASTIC | Injection | Intramuscular; Intravenous | Hikma Injectables Usa Inc. |
63037-190-25 | Fentanyl Citrate | Fentanyl Citrate | 2 mL in 1 SYRINGE, PLASTIC | Injection | Intramuscular; Intravenous | Hikma Injectables Usa Inc. |
63037-191-25 | Fentanyl Citrate | Fentanyl Citrate | 5 mL in 1 SYRINGE, PLASTIC | Injection | Intramuscular; Intravenous | Hikma Injectables Usa Inc. |
63037-191-25 | Fentanyl Citrate | Fentanyl Citrate | 5 mL in 1 SYRINGE, PLASTIC | Injection | Intramuscular; Intravenous | Hikma Injectables Usa Inc. |
70092-092-36 | Fentanyl Pf 10 Mcg/ml In 100 Ml Ns Ivb | Fentanyl Pf 10 Mcg/ml In 100 Ml Ns Ivb | 100 mL in 1 BAG | Injection | Intravenous | Quva Pharma, Inc. |
70092-092-36 | Fentanyl Pf 10 Mcg/ml In 100 Ml Ns Ivb | Fentanyl Pf 10 Mcg/ml In 100 Ml Ns Ivb | 100 mL in 1 BAG | Injection | Intravenous | Quva Pharma, Inc. |
70092-092-36 | Fentanyl Pf 10 Mcg/ml In 100 Ml Ns Ivb | Fentanyl Pf 10 Mcg/ml In 100 Ml Ns Ivb | 100 mL in 1 BAG | Injection | Intravenous | Quva Pharma, Inc. |
70092-092-36 | Fentanyl Pf 10 Mcg/ml In 100 Ml Ns Ivb | Fentanyl Pf 10 Mcg/ml In 100 Ml Ns Ivb | 100 mL in 1 BAG | Injection | Intravenous | Quva Pharma, Inc. |
70092-093-37 | Fentanyl Pf 10 Mcg/ml In 250 Ml Ns Ivb | Fentanyl Pf 10 Mcg/ml In 250 Ml Ns Ivb | 250 mL in 1 BAG | Injection | Intravenous | Quva Pharma, Inc. |
70092-093-37 | Fentanyl Pf 10 Mcg/ml In 250 Ml Ns Ivb | Fentanyl Pf 10 Mcg/ml In 250 Ml Ns Ivb | 250 mL in 1 BAG | Injection | Intravenous | Quva Pharma, Inc. |
70092-093-37 | Fentanyl Pf 10 Mcg/ml In 250 Ml Ns Ivb | Fentanyl Pf 10 Mcg/ml In 250 Ml Ns Ivb | 250 mL in 1 BAG | Injection | Intravenous | Quva Pharma, Inc. |
70092-093-37 | Fentanyl Pf 10 Mcg/ml In 250 Ml Ns Ivb | Fentanyl Pf 10 Mcg/ml In 250 Ml Ns Ivb | 250 mL in 1 BAG | Injection | Intravenous | Quva Pharma, Inc. |
70092-094-36 | Fentanyl Pf 20 Mcg/ml In 100 Ml Ns Ivb | Fentanyl Pf 20 Mcg/ml In 100 Ml Ns Ivb | 100 mL in 1 BAG | Injection | Intravenous | Quva Pharma, Inc. |
70092-094-36 | Fentanyl Pf 20 Mcg/ml In 100 Ml Ns Ivb | Fentanyl Pf 20 Mcg/ml In 100 Ml Ns Ivb | 100 mL in 1 BAG | Injection | Intravenous | Quva Pharma, Inc. |
70092-094-36 | Fentanyl Pf 20 Mcg/ml In 100 Ml Ns Ivb | Fentanyl Pf 20 Mcg/ml In 100 Ml Ns Ivb | 100 mL in 1 BAG | Injection | Intravenous | Quva Pharma, Inc. |
70092-097-43 | Fentanyl Pf 50 Mcg/ml 2ml- 3 Ml Syr | Fentanyl Pf 50 Mcg/ml 2ml- 3 Ml Syr | 2 mL in 1 SYRINGE | Injection | Intravenous | Quva Pharma, Inc. |
70092-097-43 | Fentanyl Pf 50 Mcg/ml 2ml- 3 Ml Syr | Fentanyl Pf 50 Mcg/ml 2ml- 3 Ml Syr | 2 mL in 1 SYRINGE | Injection | Intravenous | Quva Pharma, Inc. |
70092-097-43 | Fentanyl Pf 50 Mcg/ml 2ml- 3 Ml Syr | Fentanyl Pf 50 Mcg/ml 2ml- 3 Ml Syr | 2 mL in 1 SYRINGE | Injection | Intravenous | Quva Pharma, Inc. |
70092-097-43 | Fentanyl Pf 50 Mcg/ml 2ml- 3 Ml Syr | Fentanyl Pf 50 Mcg/ml 2ml- 3 Ml Syr | 2 mL in 1 SYRINGE | Injection | Intravenous | Quva Pharma, Inc. |
Frequently Asked Questions
What is the NDC number assigned to Fentanyl Pf 50 Mcg/ml 2ml- 3 Ml Syr?
Fentanyl Pf 50 Mcg/ml 2ml- 3 Ml Syr was assigned by its manufacturer with NDC product code 63037-101. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.
Which are the NDC package codes for Fentanyl Pf 50 Mcg/ml 2ml- 3 Ml Syr?
The NDC package code 63037-101-05 was assigned to a 250 mL in 1 BAG of fentanyl citrate administered intravenous via injection.
Who manufactures this product?
Fentanyl Pf 50 Mcg/ml 2ml- 3 Ml Syr is manufactured by an outsourced facility and labeled by Hikma Injectables Usa Inc.. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.
Which are the NDC crossover matchings for this product?
We found 30 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by Exela Pharma Sciences, LLC., Ssm Hlth St Clare Hosp-Fnton, SSM Health Care St. Louis d/b/a SSM Health St. Clare-Fenton, Hikma Injectables USA Inc. and QuVa Pharma, Inc. with NDC product codes 51754-9150-1, 51754-9160-1, 60652-6030-1, 60652-6030-1, 60652-6030-1, 60652-6030-1, 60652-9010-1, 63037-100-05, 63037-100-05, 63037-100-05, 63037-100-05, 63037-190-25, 63037-190-25, 63037-191-25, 63037-191-25, 70092-092-36, 70092-092-36, 70092-092-36, 70092-092-36, 70092-093-37, 70092-093-37, 70092-093-37, 70092-093-37, 70092-094-36, 70092-094-36, 70092-094-36, 70092-097-43, 70092-097-43, 70092-097-43 and 70092-097-43.